Completed OBSERVATIONAL NCT00438906

Cancer of the Pancreas Screening Study (CAPS 3) (CAPS 3)

Screening for Early Pancreatic Neoplasia

Sponsor: Johns Hopkins University

Conditions Pancreatic Neoplasm Peutz-Jeghers Syndrome

Interventions Biopsy, Fine Needle Aspiration (FNA) Secretin (human synthetic) - ChiRhoClin

Updated 12 times since 2017 Last updated: Jun 17, 2021 Started: Dec 31, 2006 Primary completion: Dec 31, 2009 Completion: Dec 31, 2009

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This observational or N/A phase trial investigates Pancreatic Neoplasm and Peutz-Jeghers Syndrome and is currently completed. Johns Hopkins University leads this study, which shows 12 recorded versions since 2006 — indicating substantial longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Status Flow

Change History

12 versions recorded

Sep 2024 — Present [monthly]

Completed
Jul 2024 — Sep 2024 [monthly]

Completed
Dec 2021 — Jul 2024 [monthly]

Completed
Sep 2021 — Dec 2021 [monthly]

Completed
Jan 2021 — Sep 2021 [monthly]

Completed

▶ Show 7 earlier versions

Nov 2020 — Jan 2021 [monthly]

Completed
Sep 2018 — Nov 2020 [monthly]

Completed
Jun 2018 — Sep 2018 [monthly]

Completed
May 2018 — Jun 2018 [monthly]

Completed
Apr 2018 — May 2018 [monthly]

Completed

Phase: NA → None
Aug 2017 — Apr 2018 [monthly]

Completed NA
Jan 2017 — Aug 2017 [monthly]

Completed NA

First recorded

Dec 2006

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Johns Hopkins University
Lustgarten Foundation
National Cancer Institute (NCI)

Data source: Johns Hopkins University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Baltimore, United States